Form 4: ResMed Executive Sells Shares for Tax Withholding
Statement of Changes in Beneficial Ownership
ResMed's Global General Counsel, Michael J. Rider, reported a disposition of company stock for tax withholding purposes related to vested Restricted Stock Units.
Summary
- Michael J. Rider, Global General Counsel of ResMed Inc., reported a transaction on June 1, 2026.
- This transaction involved the disposition of 268.742 shares of ResMed Common Stock to the issuer.
- The disposition was for tax withholding purposes related to the vesting of Restricted Stock Units granted on June 1, 2023.
- The reported price for this disposition was $190.57 per share.
- Following this transaction, Mr. Rider beneficially owns 9,488 shares of ResMed Common Stock.
- Additionally, the filing notes that Mr. Rider purchased 66.0288 shares of ResMed stock on April 30, 2026, through the ResMed Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it represents a standard administrative transaction for tax purposes related to executive compensation rather than a strategic decision to buy or sell shares based on market outlook.
Positives
- The disposition of shares was for tax withholding, a standard procedure upon vesting of equity awards.
- Michael J. Rider continues to hold a significant number of shares (9,488) after the transaction.
- Mr. Rider also participated in the Employee Stock Purchase Plan, indicating continued investment in the company.
Negatives
- A disposition of shares, even for tax purposes, represents a reduction in the reporting person's direct holdings.
Future Outlook
No specific forward-looking statements or guidance were provided in this Form 4 filing.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for executives and insiders, detailing changes in their beneficial ownership of company stock. These transactions are often related to compensation plans, tax obligations, or personal investment strategies and are closely watched by the market for insights into insider confidence.
Stakeholder Impact
- Shareholders: The transaction is a routine tax-related disposition and does not inherently signal a change in management's view of the company's prospects. The continued ownership of a substantial number of shares by Mr. Rider is a positive indicator.
- Employees: The mention of the Employee Stock Purchase Plan highlights a benefit available to employees, potentially encouraging their investment in the company.
- Management: The transaction is a standard part of executive compensation and tax management.
Key Dates
| Date | Description |
|---|---|
| 06/01/2023 | Date Restricted Stock Units were granted. |
| 04/30/2026 | Date of purchase of shares through the Employee Stock Purchase Plan. |
| 06/01/2026 | Date of the reported stock disposition transaction. |
| 06/03/2026 | Date the Form 4 was signed by the reporting person. |
Keywords
ResMed, RMD, Form 4, Insider Trading, Stock Disposition, Restricted Stock Units, Tax Withholding, Employee Stock Purchase Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.